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Abstract 
Objective: To study the correlation of duration of chronic 
HCV infection with total cholesterol and triglycerides.  
Patients & Methods: In this cross-sectional observational 
study we recruited 37 HCV infected patients who were 
diagnosed at least 6 months ago. Seven patients were 
excluded due to hyperglycemia. Patients suffering from 
metabolic disorders affecting total cholesterol and 
triglycerides were also excluded. Serum triglycerides, total 
cholesterol, and plasma glucose were measured by 
enzymatic method. Data was entered on SPSS version 16. 
Mean, standard deviation was calculated for numerical data. 
Pearson correlation was used to find association of duration 
of HCV with Total Cholesterol and Triglycerides. 
Results: Mean age of 30 subjects was 39.9±9.5 years, 
duration of HCV infection was 4.1±3.4 years and mean 
fasting plasma glucose was 81.7±6.4mg/dl. Total cholesterol 
and triglycerides were 107±30mg/dl and 72.3±23.5mg/dl 
respectively. Triglycerides showed a significant correlation 
with duration of HCV infection (p=0.024) and total 
cholesterol (p=0.001).   
Conclusion: There is a significant correlation of 
triglycerides with duration of HCV infection (p=0.024) and 
total cholesterol (p=0.001). 
Key words: Chronic hepatitis C, total cholesterol, 
triglycerides and correlation 
Introduction 
Hepatitis C virus (HCV) was identified and was named as 
non-A Non-B hepatitis in 1970 and as HCV in 1989. 1, 2 
Chronic Hepatitis C virus (CHCV) infection is an 
important cause of hepatitis  causing liver cirrhosis and end 
stage liver disease.3 Prevalence rate of HCV infection 
ranged from 0.1% to 12%, in different populations.1  
Globally estimated carrier state rate has been reported 3% 
(175 millions).1 About 200 million people (3.3% of the 
world’s population) were infected with HCV worldwide in 
2009.2  In  one study, about 10 million people (5% of 
worldwide HCV infected patients) have been reported in 
Pakistan.2 In developing countries overuse and unsafe 
injection practices causes 2 to 5 million hepatitis C virus 
infections and these infections lead to high burden of 
chronicity, disability and death.4 Liver is a vital organ and 
plays a key role in metabolism and synthesis of serum 
lipoproteins.5 Impaired lipid metabolism is closely 
associated with chronic liver disease which result in low 
levels of total cholesterol (TC) and low density lipoprotein 
cholesterol (LDL) regardless of degree of fibrosis.5 Several 
mechanisms have been proposed to alter cholesterol 
homeostasis in HCV infected patients. One of the proposed 
mechanism is through its interference with the mevalonate 
pathway, resulting in decreased cholesterol synthesis. This 
diminished synthesis may then subsequently upregulate 
LDL-receptor expression, ultimately lowering LDL 
levels.6-8 Hepatitis C viral proteins have also been shown 
to directly activate the PI3-K/AKT sign align pathway, 
resulting in activation of the master regulator sterol 
response element binding protein (SREBP), which plays a 
critical role in activation of genes essential to fatty acid 
and cholesterol biosynthesis.9-12 Additionally, infection 
with HCV is associated with reduced microsomal 
triglyceride transfer protein (MTTP), an enzyme critical 
for VLDL synthesis, and whose inhibition results in 
decreased circulating LDL and cholesterol 
levels.13Hypolipidemias have thus been found associated 
with CHCV infection through several mechanisms.14 Very 
few studies have been conducted in our setup, on the 
correlation of metabolic variables like total cholesterol and 
triglycerides in CHCV patients. Present study was planned 
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to study the correlation between duration of CHCV 
infection and serum total cholesterol and triglycerides. 
Patients and Methods 
This cross-sectional study was conducted at Pathology 
department Holy Family Hospital. About 37 anti-HCV 
antibodies positive patients of both genders and all ages, 
who were in fasting state were enrolled in the study. 
Sampling was done by non-probability convenience 
sampling. Only diagnosed cases of HCV with at least 6 
months’ post-diagnosis were included. Patients with known 
hyperlipidemias, dyslipidemia, diabetes mellitus or 
hyperglycemia, endocrine disorders affecting lipid 
metabolism and myocardial infarction were excluded from 
this study.Out of 37 patients 7 were excluded due to fasting 
hyperglycemia. Informed consent was obtained from each 
patient prior to enrolment in this study. Fasting venous 
blood sample collected in a gel tube for total cholesterol 
and triglycerides and into sodium fluoride tube for plasma 
glucose measurement. Samples were centrifuged after 
about half an hour. We analyzed these samples for serum 
triglycerides (TG), serum total cholesterol (TC) and fasting 
plasma glucose (FPG). TC, TG and glucose were measured 
by enzymatic method. Statistical package for social 
sciences (SPSS) version 16 was used for statistical 
analysis. Mean, standard deviation (SD), variance and 
skewness of, duration of HCV infection after diagnosis, 
with T.C, and TG were measured. Duration of HCV 
(DHCV) infection was considered by the time when the 
patient came to know about his infection first time after 
that the patient got advise to screen himself for viral 
hepatitis and was declared reactive for anti HCV 
antibodies by either immunochrmatography, enzyme linked 
immunosorbent assay (ELISA), or polymerase chain 
reaction (PCR). Pearson’s correlation was applied to see 
the correlation between duration of HCV infection, 
triglycerides, and total cholesterol. P. Value less than 0.05 
was considered significant. 
Results 
Baseline characteristics of total 30 patients are presented 
below in Table 1.Age of these patients ranged from 22-60 
years with mean of 38.90 years+9.488SD. Mean duration of 
HCV infection was 4.13 years+3.431 SD. Mean fasting 
plasma glucose was 81.7mg/dl±6.4 SD. Total cholesterol 
and triglycerides were 107±30 mg/dl and 72.3±23.5mg/dl 
respectively. As shown in table 2, TG showed a significant 
correlation with duration of HCV infection (P=0.024), 
however correlation of cholesterol with duration of HCV 
was not significant (p value.606) The correlation between 
TG and TC was also significant (P=0.001). 
 
Table 1: Statistical Analysis of biographic and 
biochemical Variables (n=30) 
Variable Mean SD 
Age (in years) 38.90 9.488 
Duration of HCV (in years) 4.13 3.431 
FBS (mg/dl) 81.70 6.439 
Total Cholesterol(mg/dl) 107.30 30.268 
Triglycerides (mg/dl) 72.30 23.511 
 
Table 2: Correlations different variables with 
duration of hepatitis C infection (n=30) 
 Pearson 
Correlation 
P value 
 
Total Cholesterol (TC) 
 
0.098 
 
0.606 
 
Triglycerides (TG) 
 
0.412 
 
0.024 
 
TC vs TG 
 
0.581 
 
0.001 
Correlation is significant < 0.05.  
Discussion 
Lipoproteins are closely connected to the process of 
hepatitis C virus (HCV) infection. In our study Triglycerides 
were low in majority of the patients and showed a significant 
correlation with duration of HCV infection (P=0.024).Our 
results are comparable with findings of the Perlemuter, et al, 
who also reported that the levels of triglycerides in HCV 
infected patients were moderately low.15  In 2006, D. 
Siagriset al. reported Serum TC (P < 0.0005), HDL-C (P < 
0.0005) and LDL-C (P < 0.0005) were lower in chronic 
hepatitis C patients compared with controls. They also 
reported that this finding is more pronounced in patients 
infected with HCV genotype 3a. Patients with HCV 
genotype 3a had significantly lower levels of TC, HDL-C, 
LDL-C, higher viral load and higher frequency of hepatic 
steatosis than those with other genotypes. They proposed 
that further studies are needed to define the pathophysiology 
of the relationship between lipid metabolism and HCV 
infection.16 In a study done by Corey KE et al, it was 
observed hepatitis C is associated with decreased cholesterol 
and LDL levels. This hypolipidemia resolves with successful 
hepatitis C treatment but persists in nonresponders.08Other 
studies have also reported that Hepatitis C virus infected 
patients with HCV viremia have significantly low serum TG 
and cholesterol levels.17,18 Single nucleotide polymorphism 
in interleukin 28B gene have been found and reported in  
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HCV positive patients with lower levels of triglycerides.19 
Skowroński et al observed that there was a significant 
correlation of duration of HCV infection with total 
cholesterol which is in agreement with our study. 20 In the 
same study Skowroński et al. found that there was no 
significant correlation of duration of HCV infection with 
triglycerides,20 while in our study we observed that there is 
significant correlation of duration of HCV infection with 
triglycerides. Circulating lipid levels are altered in patients 
with HCV, regardless of the duration of infection. In a 
cohort of patients with acute HCV, early infection was 
associated with reduction in LDL and total cholesterol 
levels and following  successful anti-HCV treatment, the 
lipids of these patients returned to pre-infection 
levels.7Patients with CHC also have also demonstrated 
reduced levels of circulating LDL, apolipoprotein B100 
(apoB) and total cholesterol, compared to healthy controls 
and seem to resolve after successful clearance of CHC, 
supporting the hypothesis that HCV has a direct cytopathic 
effect upon host lipid metabolism. The presence and 
degree of hypocholesterolemia carries important 
prognostic implications for patients with CHC. Elevated 
LDL and high-density lipoprotein (HDL) levels have thus 
been associated with improved rates of sustained virologic 
response.6 
Conclusion 
Serum triglycerides have a significant correlation with the 
duration of HCV infection. Chronic HCV infection is 
associated with hypotriglyceridemia. 
Limitations and Recommendations 
This was a small sample sized study and included only 
triglycerides and total cholesterol as target variables in our 
study. It is thus suggested that studies may be conducted 
with large sample size and other variables of lipid profile 
like very low-density lipoprotein (VLDL), low-density 
lipoprotein (LDL) and high-density lipoprotein cholesterol 
(HDL). Moreover it is suggested that studies are conducted 
to find out various mechanisms leading to Hypolipidemias, 
association with genotypes and effect of their treatment 
response. 
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